Ming Bo Huang to Cell Line, Tumor
This is a "connection" page, showing publications Ming Bo Huang has written about Cell Line, Tumor.
Connection Strength
0.489
-
Huang MB, Yan F, Jadoon U, Wu JY, Brena D, Johnson EL, Stiles J, Yang L, Rivers BM, Bond VC. SMR Peptide Modulates Tumor-Derived Extracellular Vesicles microRNA and Inflammatory Transcript Signatures in TNBC. Cells. 2026 Mar 19; 15(6).
Score: 0.144
-
Huang MB, Tiwari PB, ?ren A, Shelton MN, Brena D, Wu JY, Khan MB, Powell MD, Stiles JK, Johnson EL, Yan F, Yang L, Bond VC. Investigating SMR Peptide Interactions with Breast Cancer-Associated Proteins. Int J Mol Sci. 2025 Sep 11; 26(18).
Score: 0.139
-
Huang MB, Brena D, Wu JY, Roth WW, Owusu S, Bond VC. Novel secretion modification region (SMR) peptide exhibits anti-metastatic properties in human breast cancer cells. Sci Rep. 2022 08 01; 12(1):13204.
Score: 0.112
-
Huang MB, Gonzalez RR, Lillard J, Bond VC. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells. Oncotarget. 2017 Feb 14; 8(7):11302-11315.
Score: 0.077
-
Khan MB, Lang MJ, Huang MB, Raymond A, Bond VC, Shiramizu B, Powell MD. Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce A?(1-42) secretion in SH-SY5Y neural cells. J Neurovirol. 2016 Apr; 22(2):179-90.
Score: 0.017